Alector Therapeutics’ novel Alzheimer’s strategy fails in Phase 2
Alector Therapeutics said Monday that its Phase 2 trial for an experimental Alzheimer’s antibody failed, dealing a blow to what ...
Alector Therapeutics said Monday that its Phase 2 trial for an experimental Alzheimer’s antibody failed, dealing a blow to what ...
An ultra-rare enzyme deficiency that keeps infants from achieving proper muscle function among other developmental delays now has its first ...
Six months after launching with a mega-round of financing, Seaport Therapeutics has raised $225 million more to advance a lead ...
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your ...
Repare Therapeutics has three cancer drug candidates in the clinic and another one expected to enter Phase 1 by the ...
The human battle against viruses is an unending struggle for advantage. As we adapt and evolve to survive, pathogens evolve ...
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.